doi: 10.1016/j.jaad.2022.04.032.
Epub 2022 Apr 25.
Treatment at high-volume facilities is associated with improved overall survival for patients with cutaneous B-cell lymphoma
Affiliations
- PMID: 35476920
- DOI: 10.1016/j.jaad.2022.04.032
Item in Clipboard
Treatment at high-volume facilities is associated with improved overall survival for patients with cutaneous B-cell lymphoma
J Am Acad Dermatol.
2023 Jan.
No abstract available
Keywords: NCDB; case volume; cutaneous B-cell lymphoma; facility; outcomes; survival.
Conflict of interest statement
Conflicts of interest None disclosed.
Similar articles
-
Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.Am J Hematol. 2004 Apr;75(4):195-9. doi: 10.1002/ajh.20019. Am J Hematol. 2004. PMID: 15054808
-
Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival.J Am Acad Dermatol. 2019 Apr;80(4):979-989. doi: 10.1016/j.jaad.2018.10.026. Epub 2018 Oct 23. J Am Acad Dermatol. 2019. PMID: 30365997
-
Treatment of B cell lymphoma of the skin.Australas J Dermatol. 1996 May;37 Suppl 1:S34-5. doi: 10.1111/j.1440-0960.1996.tb01077.x. Australas J Dermatol. 1996. PMID: 8713009
-
Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.Cancer Control. 2012 Jul;19(3):236-44. doi: 10.1177/107327481201900308. Cancer Control. 2012. PMID: 22710899 Review.
-
Two pediatric cases of primary cutaneous B-cell lymphoma and review of the literature.Pediatr Dermatol. 2009 Jan-Feb;26(1):34-9. doi: 10.1111/j.1525-1470.2008.00843.x. Pediatr Dermatol. 2009. PMID: 19250402 Review.
Cited by
-
High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization.Arch Dermatol Res. 2024 Feb 13;316(3):86. doi: 10.1007/s00403-024-02817-4. Arch Dermatol Res. 2024. PMID: 38349538
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
